- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04907942
Feasibility and Acceptability of Click's EMA and Text Message Intervention for STRESS Management (FACE Stress)
Feasibility and Acceptability of Click's Ecological Momentary Assessment (EMA) and Text Message Intervention for STRESS Management (FACE STRESS Study)
The purpose of this study is to evaluate feasibility and acceptability of an Ecological Momentary Assessment (EMA) compared with an EMA plus automated text message intervention for stress management in participants with higher-than-average perceived stress conducted in a remote setting.
Study details include:
Study Duration: 7 months Intervention Duration: 3 weeks
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Fase 2
- Fase 1
Kontakter og plasseringer
Studiesteder
-
-
New York
-
New York, New York, Forente stater, 10013
- Click Therapeutics
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Age 22 years or older
- Must reside in an Eastern Standard Time or Central Standard Time zone
- Able to read and write in English as demonstrated by review and completion of an Informed Consent Form
- Own an SMS enabled smartphone
- Scoring >5 on the 4-item Perceived Stress Scale (reflecting higher-than-average perceived stress)
Exclusion Criteria:
- Reported cognitive impairment and/or psychiatric disorders of the psychotic spectrum
- Enrolled in another support study
- Currently receiving psychotherapy through telehealth
- PHQ-9 score of 20 or greater.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Trippel
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Aktiv komparator: EMA Alone
3 weeks of EMA, consisting of 2 surveys per day delivered via text message and email during waking hours to prompt participants to complete the survey.
|
Three weeks of EMA consisting of 2 daily surveys per day delivered during waking hours to evaluate momentary affects.
|
Eksperimentell: EMA + Automated Text Message Intervention
|
Intervention includes 3 weeks of EMA (2 daily surveys per day delivered during waking hours to evaluate momentary affects) plus 2 weeks of automated text messages delivered twice a day, which content follows constructs from The Transactional Model of Stress and Coping.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
The main outcome of the FACE STRESS study is to evaluate feasibility of an EMA and EMA plus text message intervention (EMA+).
Tidsramme: 1 Month
|
Feasibility assessed as the proportion of individuals who contacted us because they are interested in participating
|
1 Month
|
The main outcome of the FACE STRESS study is to evaluate feasibility of an EMA and EMA plus text message intervention (EMA+).
Tidsramme: 1 Month
|
Feasibility assessed by the number of eligible individuals after the initial screening
|
1 Month
|
The main outcome of the FACE STRESS study is to evaluate feasibility of an EMA and EMA plus text message intervention (EMA+).
Tidsramme: 1 Month
|
Feasibility assessed by the time taken to recruit the sample
|
1 Month
|
The main outcome of the FACE STRESS study is to evaluate feasibility of an EMA and EMA plus text message intervention (EMA+).
Tidsramme: 1 Month
|
Feasibility assessed by calculating the retention rates
|
1 Month
|
The main outcome of the FACE STRESS study is to evaluate feasibility of an EMA and EMA plus text message intervention (EMA+).
Tidsramme: 1 Month
|
Feasibility assessed by the number of participants responding to any EMA text over the 3-week study
|
1 Month
|
The main outcome of the FACE STRESS study is to evaluate acceptability of an EMA and EMA plus text message intervention (EMA+).
Tidsramme: 1 Month
|
Acceptability (satisfaction/utility) by using open-ended questions/patient interviews
|
1 Month
|
The main outcome of the FACE STRESS study is to evaluate acceptability of an EMA and EMA plus text message intervention (EMA+).
Tidsramme: 1 Month
|
Acceptability assessed by Likert-scales
|
1 Month
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Ecological Momentary Change in Affects
Tidsramme: 3 Weeks
|
Changes in Momentary Affects will be measured by using Ecological Momentary Assessments delivered twice a day for 3 weeks.
|
3 Weeks
|
Changes in Perceived Stress
Tidsramme: 7 Months
|
Changes in perceived stress will be measured by using the Perceived Stress Scale at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.
|
7 Months
|
Symptoms of Anxiety
Tidsramme: 7 Months
|
Symptoms of Anxiety will be measured by using the Generalized Anxiety Disorder-7 item scale (GAD-7) at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.
|
7 Months
|
Symptoms of Depression
Tidsramme: 7 Months
|
Change in depression will be measured by using the Patient Health Questionnaire (PHQ-9) at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.
|
7 Months
|
Symptoms of PTSD
Tidsramme: 7 Months
|
Changes in PTSD will be measured by using the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.
|
7 Months
|
Change in Resilience
Tidsramme: 7 Months
|
Changes in resilience will be measured by using the Brief Resilience Scale (BRS) at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.
|
7 Months
|
Psychological Well-being
Tidsramme: 7 Months
|
Changes in psychological well-being will be measured by using the Euthymia Scale at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.
|
7 Months
|
Loneliness
Tidsramme: 7 Months
|
Changes in perceived loneliness will be measured by a single question (item) at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.
|
7 Months
|
Self-Mastery
Tidsramme: 7 Months
|
Changes in self-mastery will be measured by using the Pearlin Self-Mastery Scale at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.
|
7 Months
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- DL-FACE-101
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Covid-19
-
HealthQuiltFullførtImmunfunksjon | Covid19 positiv pasient | Covid19 nærkontaktForente stater
-
VA Office of Research and DevelopmentAktiv, ikke rekrutterendeKOLS-pasienter og pasienter som kommer seg etter COVID19Forente stater
-
Bahçeşehir UniversityFullførtLang Covid19 | Autonom dysfunksjonTyrkia
-
Ohio State UniversityRekrutteringPost-akutt COVID19-syndrom | Lang COVID | Tilstand etter COVID19Forente stater
-
Texas Woman's UniversityNational Institutes of Health (NIH)Har ikke rekruttert ennå
-
Aarhus University HospitalUniversity of Aarhus; Pharma NordFullført
-
Cairo UniversityKasr El Aini HospitalUkjentCOVID19 lungebetennelseEgypt
-
Assistance Publique - Hôpitaux de ParisUkjent
-
Saglik Bilimleri Universitesi Gazi Yasargil Training...FullførtCovid19 og dødelighetTyrkia
-
Brugmann University HospitalRekruttering
Kliniske studier på EMA Alone
-
Northeastern UniversityNational Center for Advancing Translational Sciences (NCATS)Fullført
-
Massachusetts General HospitalBoston UniversityRekrutteringSchizofreni | PsykoseForente stater
-
The University of Hong KongAktiv, ikke rekrutterende
-
University Hospital, MontpellierCentre Hospitalier Universitaire de Nīmes; Instituto de Investigación Sanitaria... og andre samarbeidspartnereRekrutteringSelvmordstanker | Selvmordsatferd | Personlig historie om en nylig selvmordskriseFrankrike, Spania
-
Hôpital le VinatierInstitut National de la Santé Et de la Recherche Médicale, FranceHar ikke rekruttert ennåSpilleavhengighet
-
Chestnut Health SystemsNational Institute on Drug Abuse (NIDA)FullførtGjenoppretting | Rusmisbruksforstyrrelse (SUD)Forente stater
-
University of ZurichRadboud University Medical Center; Universitaire Ziekenhuizen KU Leuven; Johannes...Fullført
-
University of OklahomaRekrutteringHode- og nakkekreftForente stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RekrutteringKreftoverlevende | Fase I prostatakreft AJCC v8 | Fase II prostatakreft AJCC v8 | Stage IIIA prostatakreft AJCC v8 | Stage IIIB prostatakreft AJCC v8 | Stage IIC prostatakreft AJCC v8 | Stage III prostatakreft AJCC v8 | Stage IIIC prostatakreft AJCC v8 | Stage IIA prostatakreft AJCC v8 | Stage IIB prostatakreft... og andre forholdForente stater
-
Temple UniversityAlbert Einstein Healthcare Network; Eunice Kennedy Shriver National Institute... og andre samarbeidspartnereRekrutteringRyggmargsskaderForente stater